跳至主要内容
临床试验/NL-OMON50394
NL-OMON50394已完成4 期

Multicenter randomized controlled trial comparing Ferric(III)carboxymaltose infusion with oral iron suppletion in the treatment of perioperative anemia in patients with a colorectal carcinoma. - FIT-trial

Chirurgie0 个研究点目标入组 198 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Chirurgie
入组人数
198

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with:
  • - Colorectal carcinoma
  • - Laparoscopic or open segment resection or a low anterior resection
  • - Iron deficiency anemia: Hb <7,5 for women and Hb <-8 mmol/ L for men en
  • - Age 18 years or older
  • -Written informed consent for study participation

排除标准

  • - Palliative surgery / metastasized disease
  • - Received blood transfusion within one month before screening
  • - Serum ferritine * 800 µg/L
  • - Pregnancy
  • - Preoperative chemoradiation (Short 5x5gy = no exclusion)
  • - Contraindication for the use of Ferinject or ferrofumarate
  • - ASA classification > 3
  • - Use of erythropoietin stimulating agents within three months before screening
  • - Chronic kidney disease (GFR < 30ml/min/m)
  • - Myelodysplastic syndrome
  • - Elevated liver enzymes
  • - Hereditary Heamochromatosis
  • - Thalassemia
  • - Hemolytic anemia/ chronic hemolysis

研究者

发起方
Chirurgie

相似试验